🤖 AI Summary
Current cardiovascular risk assessment tools struggle to detect early vascular damage. This study proposes a non-invasive, deep learning–based approach that leverages routine carotid ultrasound videos to identify structural and hemodynamic features associated with vascular injury, using only hypertension as a weak label. By integrating explainable artificial intelligence (XAI) with weakly supervised learning, the method uncovers rich prognostic information embedded in standard ultrasound imaging, revealing novel anatomical and functional biomarkers. Notably, it enables interpretable risk stratification without reliance on laboratory measurements. The derived vascular injury score significantly predicts myocardial infarction, cardiac death, and all-cause mortality, demonstrating performance comparable to or better than established models such as SCORE2.
📝 Abstract
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, yet early risk detection is often limited by available diagnostics. Carotid ultrasound, a non-invasive and widely accessible modality, encodes rich structural and hemodynamic information that is largely untapped. Here, we present a machine learning (ML) framework that extracts clinically meaningful representations of vascular damage (VD) from carotid ultrasound videos, using hypertension as a weak proxy label. The model learns robust features that are biologically plausible, interpretable, and strongly associated with established cardiovascular risk factors, comorbidities, and laboratory measures. High VD stratifies individuals for myocardial infarction, cardiac death, and all-cause mortality, matching or outperforming conventional risk models such as SCORE2. Explainable AI analyses reveal that the model relies on vessel morphology and perivascular tissue characteristics, uncovering novel functional and anatomical signatures of vascular damage. This work demonstrates that routine carotid ultrasound contains far more prognostic information than previously recognized. Our approach provides a scalable, non-invasive, and cost-effective tool for population-wide cardiovascular risk assessment, enabling earlier and more personalized prevention strategies without reliance on laboratory tests or complex clinical inputs.